SCHEMBL6578780

SCHEMBL6578780

COc1c(N)ccc(Cl)c1COc1ccc2nc(C)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 5/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
CASP6 P55212 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TEC P42680 1/20 0.39
CYP2D6 P10635 1/20 0.36
NOS1 P29475 2/20 0.35
KLKB1 P03952 1/20 0.35
CYP1A2 P05177 1/20 0.35
NOS3 P29474 1/20 0.35
NOS2 P35228 1/20 0.35
TSHR P16473 2/20 0.35
MAPT P10636 2/20 0.35
NPY1R P25929 1/20 0.35
NPY2R P49146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580627 0.87 NCF1 (0.41) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6936592 0.87 KDM4E (0.42) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6578484 0.85 NCF1 (0.39) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6576073 0.82 KDM4E (0.38) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6576127 0.82 S1PR4 (0.42) LMNAPOLBALDH1A1CYP2D6KLKB1
SCHEMBL6578833 0.82 NCF1 (0.40) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6581525 0.78 NCF1 (0.39) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6580770 0.77 NCF1 (0.40) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6581464 0.77 KDM4E (0.44) NCF1KDM4ELMNAPOLBCASP6
SCHEMBL6581350 0.77 BDKRB2 (0.37) KDM4ELMNAALDH1A1KLKB1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed